home / stock / gene / gene quote
Last: | $2.221 |
---|---|
Change Percent: | -0.92% |
Open: | $2.2 |
Close: | $2.221 |
High: | $2.269 |
Low: | $2.1552 |
Volume: | 20,122 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.221 | $2.2 | $2.221 | $2.269 | $2.1552 | 20,122 | 04-26-2024 |
$2.18 | $2.31 | $2.18 | $2.31 | $2.1 | 32,104 | 04-25-2024 |
$2.25 | $2.42 | $2.25 | $2.4571 | $2.12 | 28,226 | 04-24-2024 |
$2.39 | $2.41 | $2.39 | $2.44 | $2.26 | 17,627 | 04-23-2024 |
$2.37 | $2.29 | $2.37 | $2.413 | $2.19 | 23,618 | 04-22-2024 |
$2.32 | $2.4 | $2.32 | $2.47 | $2.13 | 64,337 | 04-19-2024 |
$2.44 | $3.15 | $2.44 | $3.2 | $2.3 | 89,566 | 04-18-2024 |
$3.16 | $3.28 | $3.16 | $3.28 | $3.1 | 13,533 | 04-17-2024 |
$3.17 | $3.27 | $3.17 | $3.3 | $3.045 | 28,303 | 04-16-2024 |
$3.2701 | $3.38 | $3.2701 | $3.38 | $3.21 | 15,770 | 04-15-2024 |
$3.321 | $3.35 | $3.321 | $3.59 | $3.2001 | 42,226 | 04-12-2024 |
$3.2 | $3.05 | $3.2 | $3.2 | $3.0006 | 44,736 | 04-11-2024 |
$2.958 | $3 | $2.958 | $3.03 | $2.885 | 37,481 | 04-10-2024 |
$2.88 | $2.92 | $2.88 | $2.94 | $2.86 | 9,792 | 04-09-2024 |
$2.82 | $2.87 | $2.82 | $2.87 | $2.82 | 3,706 | 04-08-2024 |
$2.78 | $2.898 | $2.78 | $2.898 | $2.71 | 8,828 | 04-05-2024 |
$2.82 | $2.85 | $2.82 | $2.89 | $2.7 | 43,323 | 04-04-2024 |
$2.79 | $2.71 | $2.79 | $2.9 | $2.69 | 34,526 | 04-03-2024 |
$2.71 | $2.95 | $2.71 | $2.95 | $2.7 | 35,108 | 04-02-2024 |
$2.84 | $2.95 | $2.84 | $2.95 | $2.7905 | 22,309 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Genetic Technologies Ltd Company Name:
GENE Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG", or "Genetic Tech...
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, t...
MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announced that it has entered into a ...